108 related articles for article (PubMed ID: 8781823)
21. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty.
Leesar MA; Stoddard MF; Dawn B; Jasti VG; Masden R; Bolli R
Circulation; 2001 Jun; 103(24):2935-41. PubMed ID: 11413083
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty.
Lee TM; Su SF; Chou TF; Tsai CH
J Am Coll Cardiol; 2002 Mar; 39(5):871-7. PubMed ID: 11869855
[TBL] [Abstract][Full Text] [Related]
23. Effect of time interval between two balloon inflations on ischemic preconditioning during coronary angioplasty.
Tanaka T; Oka Y; Tawara I; Sada T; Kira Y
Cathet Cardiovasc Diagn; 1997 Nov; 42(3):263-7. PubMed ID: 9367098
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of repeated balloon inflation in angioplasty as a clinical model of ischemic preconditioning.
Sasaki Y; Sakai R; Furuta S
Jpn Heart J; 1995 Nov; 36(6):719-28. PubMed ID: 8627978
[TBL] [Abstract][Full Text] [Related]
25. Effect of pravastatin on myocardial protection during coronary angioplasty and the role of adenosine.
Lee TM; Su SF; Chou TF; Tsai CH
Am J Cardiol; 2001 Nov; 88(10):1108-13. PubMed ID: 11703953
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty.
Leesar MA; Jneid H; Tang XL; Bolli R
J Am Coll Cardiol; 2007 Apr; 49(15):1607-1610. PubMed ID: 17433950
[TBL] [Abstract][Full Text] [Related]
27. Ischaemic preconditioning: an intracoronary electrocardiographic study.
Bhargava B; Chandra S; Kaul U; Bahl VK; Wasir HS
Indian Heart J; 1996; 48(2):129-32. PubMed ID: 8682551
[TBL] [Abstract][Full Text] [Related]
28. Aminophylline reduces cardiac ischemic pain during percutaneous transluminal coronary angioplasty.
Hashino T; Ikeda H; Ueno T; Imaizumi T
J Am Coll Cardiol; 1996 Dec; 28(7):1725-31. PubMed ID: 8962558
[TBL] [Abstract][Full Text] [Related]
29. Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans.
Leesar MA; Stoddard MF; Xuan YT; Tang XL; Bolli R
J Am Coll Cardiol; 2003 Aug; 42(3):437-45. PubMed ID: 12906969
[TBL] [Abstract][Full Text] [Related]
30. [Effects of the time interval between the first and second balloon inflations on ischemic preconditioning during percutaneous transluminal coronary angioplasty].
Tanaka T; Oka Y; Tawara I; Sada T; Kira Y
J Cardiol; 1996 Jun; 27(6):303-8. PubMed ID: 9062590
[TBL] [Abstract][Full Text] [Related]
31. Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosine.
Heidland UE; Heintzen MP; Schwartzkopff B; Strauer BE
Am Heart J; 2000 Nov; 140(5):813-20. PubMed ID: 11054630
[TBL] [Abstract][Full Text] [Related]
32. Preconditioning effect during coronary angioplasty in patients with stable angina pectoris.
Sakai K; Yamagata T; Teragawa H; Matsuura H; Chayama K
Intern Med; 2002 Jul; 41(7):509-15. PubMed ID: 12132516
[TBL] [Abstract][Full Text] [Related]
33. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide.
Klepzig H; Kober G; Matter C; Luus H; Schneider H; Boedeker KH; Kiowski W; Amann FW; Gruber D; Harris S; Burger W
Eur Heart J; 1999 Mar; 20(6):439-46. PubMed ID: 10213347
[TBL] [Abstract][Full Text] [Related]
34. [Protection and "preconditioning" of the human heart during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole administration].
Strauer BE; Heidland UE; Vogt M; Schwartzkopff B; Heintzen MP
Med Klin (Munich); 1995 Mar; 90(3):125-30. PubMed ID: 7723712
[TBL] [Abstract][Full Text] [Related]
35. Effects of K(ATP) channel blockade by glibenclamide on the warm-up phenomenon.
Tomai F; Danesi A; Ghini AS; Crea F; Perino M; Gaspardone A; Ruggeri G; Chiariello L; Gioffrè PA
Eur Heart J; 1999 Feb; 20(3):196-202. PubMed ID: 10082152
[TBL] [Abstract][Full Text] [Related]
36. Analgesic effects of adenosine in syndrome X are counteracted by theophylline: a double-blind placebo-controlled study.
Eriksson BE; Sadigh B; Svedenhag J; Sylvén C
Clin Sci (Lond); 2000 Jan; 98(1):15-20. PubMed ID: 10600654
[TBL] [Abstract][Full Text] [Related]
37. Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty.
Ungi I; Ungi T; Ruzsa Z; Nagy E; Zimmermann Z; Csont T; Ferdinandy P
Chest; 2005 Sep; 128(3):1623-8. PubMed ID: 16162767
[TBL] [Abstract][Full Text] [Related]
38. Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk.
Argaud L; Rioufol G; Lièvre M; Bontemps L; Legalery P; Stumpf M; Finet G; Itti R; André-Fouët X; Ovize M
Eur Heart J; 2004 Nov; 25(22):2019-25. PubMed ID: 15541838
[TBL] [Abstract][Full Text] [Related]
39. Experimentally induced ischaemic pain in healthy humans is attenuated by the adenosine receptor antagonist theophylline.
Segerdahl M; Karelov A
Acta Physiol Scand; 2004 Mar; 180(3):301-6. PubMed ID: 14962012
[TBL] [Abstract][Full Text] [Related]
40. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction.
Desmet W; Bogaert J; Dubois C; Sinnaeve P; Adriaenssens T; Pappas C; Ganame J; Dymarkowski S; Janssens S; Belmans A; Van de Werf F
Eur Heart J; 2011 Apr; 32(7):867-77. PubMed ID: 21196444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
